Proton Therapy Market Size, Share, and Trends 2025 to 2034

Proton Therapy Market Size and Forecast 2025 to 2034

The global proton therapy market size is estimated at USD 572.5 billion in 2024 and is anticipated at USD 648.65 billion by 2025, and expected to reach around USD 1,995.62 billoin by 2034, expanding at a CAGR of 13.30% from 2025 to 2034.

Proton Therapy Market Key Takeaways

• By indication, the CNS cancer segment is growing CAGR of 12.5% from 2024 to 2034.
• By product type, the accelerator segment is poised to reach a CAGR of 13.4% from 2024 to 2034.
• By end user, the hospital segment is expected to hit a CAGR of 13.7% from 2024 to 2034.
• By region, Asia-Pacific is anticipated to grow at a CAGR of 15.2% from 2024 to 2034.

U.S. Proton Therapy Market Size and Growth 2025 to 2034

The U.S. proton therapy market size is evaluated at USD 172.32 billion in 2024 and is predicted to be worth around USD 612.01 billion by 2034, rising at a CAGR of 13.49% from 2025 to 2034.

North America holds the market with the highest market share of over 43% in 2024 with increased facilities in the region with rising chronic disorders among the population and increasing patients among the population changing lifestyle, and dietary intake. Which boosts the market of proton therapy during the forecast period. New advanced technologies developed in the market with increasing skills in the professionals and increased government support for integration of the new developments in proton therapy and to install in the health care center. The key market players are the major role players in the proton therapy market with increased funding from the key market helping to grow the market of proton therapy market.

U.S. Leads Proton Therapy with New Centers and Expanding Access

The United States leads the North America proton therapy market, which was fueled by an increasing incidence of cancer and an existing healthcare infrastructure. As of 2024, there are 43 proton therapy centers with 113 treatment rooms in the U.S. In California, much activity is happening with the approval of a next-generation UCSF cancer treatment center in the Dogpatch area of San Francisco. Proton therapy acceptance continues to grow as more insurance is covering the treatment and more patients are understanding the benefits proton therapy provides.

Japan Drives the Asia Pacific Proton Therapy Market with Technological Innovation

Asia Pacific is a region where heavy growth is occurring in the proton therapy market. Japan has led the way, having longstanding technologies and government investment. Japan is investing heavily in advanced radiotherapy technologies (such as proton therapy) in relation to its aging population and high rates of cancer. Naturally, Japan will have a growing cancer care infrastructure and professional education to prepare for an increase in proton therapy service provision.

Market Overview

Proton therapy is one of the most widely used therapy in the market with increased precision, and accuracy, of radiation therapy which involves the eradication of the cancerous cell and the prevention of the spread of malignant cells in the surrounding tissues. Proton therapy with the developments in radiation therapy is the type of particle therapy mostly used to treat the various types of cancer.

Proton therapy comes under external beam radiotherapy with deposition of the proton for radiation therapy. Increased focus on the tumor with limitations of the entry of the radiation on the tumor with reduced focus on the surrounding tissues helps to grow the market of proton therapy. Increased latest developments in proton therapy with enhanced efficiency of the proton therapy. The rising benefits of proton therapy in the prevention of various types of cancer with advanced technologies developed help to expand the market of proton therapy during the forecast period.

The outbreak of Covid-19 on proton therapy a negative and positive effects on the market. The wide spread of the coronavirus with rising infection and reduced number of patients visiting the hospital for treatment. Imposed rules in the region from the government during the covid-19 led to a decrease in the production and manufacturing of proton therapy. The post-pandemic situation in proton therapy with increased demands from the customer for radiation therapy and enhance developments in proton therapy during the forecast period.

Proton Therapy Market Growth Factors

The advance developed technologies in the proton therapy market and enhanced utilization of proton therapy in the health care sector with the increasing number of chronic disorders such as cancer with increased demands for proton therapy for patients with increased efficiency of the therapy, enhanced accuracy of the treatment with prevention of the spread of the cancerous cells to other surrounding tissues encourages to grow the market rate of proton therapy with the rising number of patients and enhance demands. Increased research and development of the proton therapy in the market for the development of the advanced technologies in the proton with increased efficiency of the proton therapy market, rising accuracy and precision help to grow the market of proton therapy.

Increased investment from the market players in the development of proton therapy and continuous research and development help to expand the market of proton therapy. Enhance availability of proton therapy with increased acquisition of the proton therapy from the customer with rising disorder help to boost the market growth. Increased providence from the government from various regions for the new development of the technologies in proton therapy and increased policies by the government such as reimbursement with increased benefits help to grow the market rate of proton therapy during the forecast period.

Impact of covid on the proton therapy market with the increased number of patients visiting the hospital helped to expand the market of proton therapy with the increasing number of patients with chronic disorders such as cancer and technologies developed with improving software development helped to expand the market of proton therapy with increased connectivity and wide acceptance of the therapy from the market to enhance the market of proton therapy.

Market Scope

Market Dynamics

Drivers

• Globally rising cancer disorder - Significant rise in the proton therapy market with increasing cancer disorders among the population with changing lifestyles of the people changing habits of dietary intake and increased demands from the medical sector due to the increasing number of patients and increased radiation therapies for eradication of the cancerous cell and prevention of the wide spread of the virus. Improved advanced technologies in the development of the proton therapy market with increased efficiency of the therapy with increasing results help to drive the market of proton therapy during the forecast period.
• Increased advanced technologies in proton therapy with enhanced benefits of the proton therapy such as increased accuracy, precision, and control of the radiations involved in the proton therapy with decreasing the side effects of the proton therapy and rising demands from the market with enhanced utilization in the pediatric patients. Enhance acquisition of proton therapy in treating pediatric patients with reduced costing of the proton therapy involved for treating the pediatric patients with less adverse effects helps to boost the market of proton therapy with increased market revenue share.

Key Market Challenges

• Visualization of the tumor - Major problem faced in proton therapy is during performing the particle therapy involved in proton therapy is low visualization of the tumor or cancerous cells involved in cancer. Enhance difficulties in visualizing only the tumor and no entry of radiation to the surrounding tissues and prevention of the disorder from spreading the malignant cells. Increased rules and effects of radiation therapy on other tissues may reduce the market growth of proton therapy.
• The increased cost of the proton therapy - Proton therapy is involved in treating the cancer disorder and advanced developed technologies in proton therapy with increased accuracy, precision, and efficiency. This led to the increasing cost of proton therapy may hamper the market of proton therapy with reduced demands from the customers for the proton therapy. Proton therapy market with decreased revenue share and declined growth.
• Lack of skill - Launch of new advance developed technologies in the proton therapy market with new techniques involved for carrying out the procedure in the health care center. Lack of skill among the individual for carrying out the procedure involved in proton therapy has halted the market of proton therapy with reduced market share. Decreased confidence about the treatment among patients may challenge the market of proton therapy to grow.

Key Market Opportunities

• Rising economic development - The rapid acceptance of advanced developed technologies with increasing healthcare facilities increasing expenditure in the medical sector with rising demands from the patients due to increasing chronic disorders such as cancer help to expand the market of proton therapy during the forecast period with the increasing economy of the region and increased focus on the new developments with increased efficiency of the proton therapy in the market.
• Government support - Governments from various regions with the active participation of the government in the health care sector with developments in radiation therapy for eradication of the cancer disorder and increasing investment from the government for integration of new therapies in the health care sector with development in the health care infrastructure help to drive the market of proton therapy during the forecast period.
• The key market players - The key market players involved in the proton therapy play a major role to boost the market of proton therapy with an increase in research and development with constant research in proton therapy with increased efficiency, accuracy, and precision help to expand the market of proton therapy with an increase in revenue share.

Product Insights

The accelerator is involved in the segment of proton therapy with the largest market share of around 51% in 2024 with an increase in the share of the proton ton therapy and rapid acceptance from the customer due to the rising number of patients with cancer and the cost efficiency of the proton therapy. Increased interest by the government in the development of new technologies helps to propel the market of proton therapy during the forecast period.

Indication Insights

Central nervous system cancer held the highest market share of around 37% in 2024. The increasing prevalence of chronic disorders such as cancer is the largest growing disorder among the population with increasing demands from the customer for new advanced technologies in the radiation therapy market which boost the market of proton therapy. Breast cancer is also projected as the largest market rising factor with increased demands for therapies with advance technology encouraging the market of proton therapy to grow with increasing share.

End-User Insights

The hospital segment has held the highest market share 57% in proton therapy with increasing demands from the customer with the increasing number of patients with cancer disorder and an increasing number of policies imposed by the government such as reimbursement and developing infrastructure in the healthcare center with developed technologies installed in the hospitals with rising demands help to grow the market rate to a larger extend.

Proton Therapy Market Companies

• IBA Worldwide
• Varian medical systems, Inc
• HItachi, Ltd
• Mevion medical systems
• Sumitomo Heavy Industries, Ltd
• Optivus Proton Therapy
• Advanced Oncotherapy plc
• ProTom International
• Mitsubishi Corporation
• ProNova Solutions LLC
• Sun Nuclear Corporation
• Provision Healthcare
• Koninklijke Philips N.V
• Elekta AB
• GE Healthcare
• Best Cyclotron Systems
• Ray Search Laboratories
• Permedics

Recent Developments

• In March 2025, Apollo Hospitals partnered with Ion Beam Applications (IBA) to bring Proteus One Proton Beam Therapy to India, revolutionizing cancer care with advanced technology. The introduction of the Proteus One system, featuring the DynamicARC® beam delivery technology, is expected to revolutionize cancer treatment by providing more precise, personalized, and effective therapies.
• In May 2024, IHH Healthcare, a world-leading integrated healthcare provider, reinforced its position as Asia’s leading cancer care provider with the official opening of the Mount Elizabeth Proton Therapy Centre in Singapore.
• In January 2024, OncoRay launched the world’s first whole-body MRI-guided proton therapy system. This marked the start of scientific operation using the prototype, which is designed to enable real-time MRI tracking of moving tumours during proton therapy.
• In the year 2021 April, the Collaboration of Tractebel and IBA worldwide with increased support to the agreement and increased designing of the proton therapy and improved infrastructures.
• In the year 2019 January, Varian Medical System, inc collaborated with Oncora medical. Enhance market rate with the rising collaboration of companies for enhancing market growth. Increased software developments with enhance accuracy and precision of the newly developed proton therapy in prevention of the oncology disorder.

Segments Covered in the Report

By Indication 

• Breast cancer
• Prostate cancer
• CNS cancer
• Head and Neck cancer
• Others

By Product

• Accelerator
• Beam transport system
• Bean delivery system
• Nozzle and image viewers
• Patient positioning system

By Type

• Rotating Proton Therapy Systems
• Non-Rotating Proton Therapy Systems 

By Set-Up Systems

• Multi-Room Systems
• Compact/ Single-Room Systems 

By Application Type

• Treatment Applications
• Research Applications

By End-User

• Hospitals
• Proton therapy center
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)